酒精发酵过程中酿酒酵母耐受环境胁迫的研究进展

提高酿酒酵母细胞耐受环境胁迫（高渗透压、高浓度酒精和高温）的能力对酒精工业生产具有重要的意义。对提高酿酒酵母耐受性的研究方法和策略的发展历程进行了综述。基因组学、转录组学和蛋白质组学等现代组学技术在这一领域的研究获得了广泛的应用。这些技术将提供期待的信息,去理性改造并获得更加耐受胁迫的工业酵母菌株。     

糖原合酶激酶-3，一个信号通路的重要调控因子

糖原合酶激酶-3 (glycogen synthase kinase-3,GSK-3) 是一种多功能的丝氨酸／苏氨酸蛋白激酶,在蛋白质合成、信号传递、细胞增殖、细胞分化、神经功能、肿瘤形成及胚胎发育等众多细胞进程中均扮演重要的角色.GSK-3 能够使多种底物发生磷酸化,并参与胰岛素、Wnt及Hedgehog 等多个信号通路的调控. GSK-3抑制剂在信号通路中能有效地抑制病理情况下GSK-3活性的异常增高,达到治疗的目的.GSK-3的抑制剂将作为一种潜在的药物对治疗糖尿病、阿尔海默茨症、肿瘤等疾病发挥效用.     

A New Species of the Genus Protobothrops(Squamata: Viperidae) from Southern Tibet,China and Sikkim,India

A new species of the genus Protobothrops Hoge Romano-Hoge, 1983, was described from Jilong County, southern Tibet, China, and Chungthang, northern Sikkim, India. It differs from congeners by the following characters: 1) relatively large body size(total length up to 1510 mm); 2) dorsal scale rows 25–25–19; 3) except for the smooth outermost row, dorsal scales are weakly keeled; 4) relatively high number of ventral(198–216) and subcaudal(65–76 pairs) scales; 5) 7–8 supralabials; 6) 11 to 13 infralabials; 7) dorsal head uniform dark brown, laterally a reddish-brown obscure postocular streak; 8) dorsum of trunk and tail olive, with distinct black edged red brown transverse bands across the body and tail; and 9) eye from bright brown and reddish brown to mildly brown. The new species was also observed from the Haa Valley in western Bhutan.     

A New Species of the Genus Leptolalax(Anura: Megophryidae) from Northern Thailand

A new species of the genus Leptolalax is described from Doi Saket, Chiang Mai Province, northern Thailand. The new species is distinguished from its congeners by the following combination of characters: 1) adult size large(male SVL 45.8-52.5 mm); 2) tympanum distinct; 3) skin of dorsal surface mostly smooth, with distinct tubercles on dorsal and lateral parts of the body; 4) ventrolateral glandular ridge distinct and complete; 5) lateral body and groin covered with dark brown or black spots; 6) throat, chest, and belly nearly immaculate white; and 7) bi-colored iris, upper onethird golden, and lower two-thirds gray. Molecular phylogenetic analysis of mitochondrial 16S rRNA further distinguishes it from its congeners for which sequences are available.     

4种中草药及其复方抗马拉色菌体的外药敏实验

目的观察苦参、当归、侧柏叶和白鲜皮及观察苦参、当归、侧柏叶和白鲜皮、混合药液与主要有效成分对4株CBS马拉色菌标准株的体外抑菌效果。方法通过液基稀释法,用含橄榄油的液体培养基测定各药液对马拉色菌的抑制作用。结果最小抑菌浓度（MIC）由小到大排列分别为：白鲜碱、苦参碱、苦参、侧柏叶、氧化苦参碱、侧柏叶＋当归（二仙丸）、混合药液（侧柏叶＋当归＋苦参＋白鲜皮）、白鲜皮、二仙丸＋苦参、苦参＋白鲜皮、二仙丸＋白鲜皮、槲皮素、当归、阿魏酸。结论4种中草药及其混合药液、主要有效成分均有抑制马拉色菌的作用。     

帕罗西汀血药浓度检测方法研究进展

帕罗西汀为5-羟色胺（5-HT）阻断药,具有起效快、疗效好、不良反应低等优点,为目前临床上常用抗抑郁症药物。帕罗西汀疗效和不良反应与该药血药浓度密切相关,并且个体差异性较大。因此,研究开发专一性强、灵敏度高的血药浓度检测方法十分必要,具有重要的临床和实践意义。本文综述帕罗西汀血药浓度检测时血样的前处理方法,同时对高效液相色谱法和气相色谱法检测帕罗西汀血药浓度进展进行论述,为该领域的临床合理用药和相关领域的研究提供借鉴。     

不同麻醉和术后镇痛方式对中老年胸科手术后胰岛素抵抗的影响

目的：探讨不同麻醉和术后镇痛方式对中老年胸科手术后胰岛素抵抗的影响。方法：中老年胸科手术患者80例随机分为治疗组与对照组各40例,两组都采用开胸手术治疗,于手术结束前30min硬膜外腔给予镇痛,治疗组采用舒芬太尼镇痛,对照组采用地佐辛镇痛。结果：两组镇痛后2h与镇痛后24h的HR和MVP对比差异明显（P〈0．05）,同时对照组不同时间点的组内对比差异明显（P〈0．05）,治疗组组内对比无明显差异。治疗组在镇痛后2h与镇痛后24h的VAS评分都明显少于对照组（P〈0．05）,Ramsay评分治疗组高于对照组（P〈0．05）。治疗组组内不同时间点胰岛素含量和胰岛素敏感性对比无明显差异,而对照组对比差异明显（P〈0．05）,同时镇痛后组间对比也有明显差异（P〈0．05）。结论：相对于地佐辛,舒芬太尼用于中老年胸科手术术后疼痛镇痛效果良好,能有效地抑制胰岛素抵抗与应激反应的发生,有很好的应用效果。     

吐鲁番市胃食管反流病发生相关危险因素分析（附280例报道）

目的：探讨280例胃食管反流病（GERD）的分布特点及危险因素。方法：对临床诊断和胃镜确诊的280例GERD患者进行临床和风险因子相关性分析。结果：不论汉族还是维族,男性患者比例均明显高于女性;汉族患者高发年龄段早于维族患者（z=-2．939,P=0．003,）;汉族和维族患者占反流性食管炎和Barrett食管比例分别为42．4％、81_3％及56．5％、18．8％,其中汉族患者Barrett食管比例较高（X2=14．358,P=0．000）;肥胖、习惯性便秘、重体力活动者、饮食习惯不良在维族患者中的比例较高（P〈0．001）。结论：GERD与性别、年龄密切相关,男性多于女性,汉族患者发病年龄高峰旱于维族患者;汉族患者Barrett食管发生比例高于维族患者;肥胖、习惯性便秘、重体力活动、饮食习惯不良可能是GERD尤其是维族人群GERD的危险因素。     

上颌第一前磨牙三维模型的建立与研究

目的：建立上颌第一前磨牙三维模型,以辅助牙体解剖学数字化教学和指导临床根管治疗术。方法：对人离体上颌第一前磨牙通过ConebeamCT扫描,获得DICOM格式影像,将获得的影像定位后利用Mimicsl0．0三维重建软件采集牙釉质、牙本质及髓腔的点数据,然后将采集到的点数据导入到MagicslO．0软件进行面网格化,将网格化后的图像标本进行光滑处理后保存,再次利用MimicslO．0三维重建软件进行数据处理,最终获得清晰的牙体及根管系统三维立体图像。结果：准确的建立了包含牙釉质、牙本质、牙髓腔的三维立体模型。结论：本实验方法建立的上颌第一前磨牙的三维模型,具有极高的真实性和精确性,对辅助教学、指导临床根管治疗都具有重要意义。为牙体解剖教学和口腔临床应用提供了一种简捷而精确的建模方法。     

Trehalose Maintains Bioactivity and Promotes Sustained Release of BMP-2 from Lyophilized CDHA Scaffolds for Enhanced Osteogenesis In Vitro and In Vivo

Calcium phosphate (Ca-P) scaffolds have been widely employed as a supportive matrix and delivery system for bone tissue engineering. Previous studies using osteoinductive growth factors loaded Ca-P scaffolds via passive adsorption often experience issues associated with easy inactivation and uncontrolled release. In present study, a new delivery system was fabricated using bone morphogenetic protein-2 (BMP-2) loaded calcium-deficient hydroxyapatite (CDHA) scaffold by lyophilization with addition of trehalose. The in vitro osteogenesis effects of this formulation were compared with lyophilized BMP-2/CDHA construct without trehalose and absorbed BMP-2/CDHA constructs with or without trehalose. The release characteristics and alkaline phosphatase (ALP) activity analyses showed that addition of trehalose could sufficiently protect BMP-2 bioactivity during lyophilization and achieve sustained BMP-2 release from lyophilized CDHA construct in vitro and in vivo. However, absorbed BMP-2/CDHA constructs with or without trehalose showed similar BMP-2 bioactivity and presented a burst release. Quantitative real-time PCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) demonstrated that lyophilized BMP-2/CDHA construct with trehalose (lyo-tre-BMP-2) promoted osteogenic differentiation of bone marrow stromal cells (bMSCs) significantly and this formulation could preserve over 70% protein bioactivity after 5 weeks storage at 25°C. Micro-computed tomography, histological and fluorescent labeling analyses further demonstrated that lyo-tre-BMP-2 formulation combined with bMSCs led to the most percentage of new bone volume (38.79% ±5.32%) and area (40.71% ±7.14%) as well as the most percentage of fluorochrome stained bone area (alizarin red S: 2.64% ±0.44%, calcein: 6.08% ±1.37%) and mineral apposition rate (4.13±0.62 µm/day) in critical-sized rat cranial defects healing. Biomechanical tests also indicated the maximum stiffness (118.17±15.02 Mpa) and load of fracture (144.67±16.13 N). These results lay a potential framework for future study by using trehalose to preserve growth factor bioactivity and optimize release profile of Ca-P based delivery system for enhanced bone regeneration.